Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

Impaired autophagy may contribute to alopecia areata.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

A rare case of trichothiodystrophy was found with autism, seizures, and mental retardation.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

SQSTM1 gene issues may increase the risk of alopecia areata.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

A specific gene change is linked to severe hair loss.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Sox13 is a marker for early hair follicle development but not essential for skin and hair growth.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

ACOD1 deficiency worsens hair loss by causing cell aging and mitochondrial problems, but 4-OI may help.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.